|
Wednesday, August 22
8:30 Registration and Morning Coffee
9:00 – 12:00 Unit 1: Writing SOPs
Compliance with the requirements of a Good Laboratory Practice (GLP)
Study Protocol can only be achieved if the analytical methods and other study
conduct operations are properly described in written Standard Operating
Procedure (SOP) documents. Failure to have adequate study documentation and SOPs
shows up frequently in FDA warning letters to institutions having GLP compliance
problems. This three-hour seminar will provide attendees with
essential tools for the job of creating a compliant SOP system. It will cover:
- How to develop an effective SOP and write clear,
practical instructions
- How to set up your SOP process so employees know who’s
responsible for what and how often to review and update procedures
- The details to include — and avoid — when drafting a SOP
- Steps for monitoring and auditing SOP compliance
|

|
Alex D. Kanarek, Ph.D., Principal, AK Consulting
Dr. Alex Kanarek, Principal of AK Consulting, has more than 30
years of experience in the biopharmaceutical industry with the Wellcome
Foundation (now GlaxoSmithKline) in the UK and Connaught Laboratories (now
Sanofi Pasteur) in North America. He established his consulting practice in
1993, specializing in regulatory compliance in drug development laboratories and
manufacturing plants, technology transfer and biopharmaceutical product
development.
|
|
Dr. Kanarek has written Guides to Good Laboratory
Practice, Good Manufacturing Practice, Good Validation Practice, Good Clinical
Practice and to Good Facility Design. He is on the editorial advisory board of
the BioProcess International journal.
Dr. Kanarek received his BS in Microbiology from Imperial
College, University of London, his Ph.D. on virus research from Cambridge
University and Membership (MCIM) in international pharmaceutical business
development from the UK Royal Chartered Institute of Marketing
|
|
12:00 – 1:30 Break for Lunch (on your own)
1:00 – 1:30 Unit 2 Registration
1:30 – 5:15 Unit 2: Documentation, Validation and Qualification
1:30 GLP Compliance -The Challenge for Start Ups: Working Together to
Build Strong Documentation
Interactive discussion about documentation and tracking in the GLP
arena and how to use systems readily available in the lab or through the
computer to help develop strong documentation/archiving needed in GLP studies.
|
1) How:
- How do you prepare your lab for incoming testing and
samples.
- An example sample will be used to initiate a GLP test
|
3) Why:
- Recreate a study through accurate logging and numbering
systems.
- After testing: Reports, QAU, Archiving, pdf files
|
|
2) What:
- What are the basics for a start up?
- Pre testing:Tracking, Data forms, Sponsors, QAU
- During testing: Protocol, QAU
|
4) Continued Improvements
- Improving templates for all systems, increasing
efficiency and building from audit findings
|
|

|
Ann Wright, Ph.D., RAC, Principal Scientist,
Research Development Technical Support, CIBA Vision
Dr. Ann M. Wright has been employed in the contact lens
industry for over 14 years. She has made numerous presentations at various
professional meetings highlighting the interaction of in vitro tissue culture
with contact lens products and materials. She also has professional journal
publications on both cellular biology and microbiology. |
| She is a certified regulatory affairs professional and is
study director and sponsor for GLP studies for product submissions. She has
presented online training, professional organization symposiums and provides
both external and internal training to individuals on GLP guidelines. She
recently supported the biotechnology initiative for RAPS and CRDF in Kazackhstan. Her career has involved
fucosyltransferase studies, P. falciparum tissue culture, recombinant DNA studies with P.
putida, education and presently is involved in cell biology/ toxicology methods
and immunological assays involved with the contact lens and lens care products.
Her undergraduate studies were at Hope College and shereceived doctoral
degree in pharmaceutics from Mercer University.
|
2:30 Information Technology - Infrastructure Change
Control
The transition for the Information Technology (IT) function from a
research / academic mode to a GLP environment can be challenging for the entire
organization. Maintaining Electronic data generated by the laboratories requires
a comprehensive methodology from backup and restore, hardware/software
qualifications, validation and change control.
Sam Mistretta, Compliance Specialist, Informatics, CyberVal Pharma,
Inc.
- Degreed in Interdisciplinary Life Sciences/Chemistry
at the University of South Florida. Experience with major pharmaceuticals in
the Microbiology, Quality Control, and Research & Development laboratories.
- Microsoft Certified
- Systems Engineer (MCSE) and laboratory informatics
specialist.
- Last seven years as a consultant to
biopharmaceutical, pharmaceutical, and medical device industries.
3:30 – 4:10 Refreshment Break 4:10 Bioanalytical Method Validation:
Common Pitfalls to Avoid
An interactive session will be presented that focus on the elements
that need to be validated, the proper execution of bioanalytical method
validation and the common pitfalls to avoid.
Delfina Buening, Research Scientist, Chemistry Lab, NSF
International
Ms. Buening has served either as research scientist or QAU for
various GLP studies. Having worked on “both sides of the fence” she has the
practical knowledge on what to look for and pitfalls to avoid in GLP studies. |
5:15 End of Day One
|